These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Selective potentiation of (α4)3(β2)2 nicotinic acetylcholine receptors augments amplitudes of prefrontal acetylcholine- and nicotine-evoked glutamatergic transients in rats. Grupe M; Paolone G; Jensen AA; Sandager-Nielsen K; Sarter M; Grunnet M Biochem Pharmacol; 2013 Nov; 86(10):1487-96. PubMed ID: 24051136 [TBL] [Abstract][Full Text] [Related]
14. Unraveling amino acid residues critical for allosteric potentiation of (α4)3(β2)2-type nicotinic acetylcholine receptor responses. Wang ZJ; Deba F; Mohamed TS; Chiara DC; Ramos K; Hamouda AK J Biol Chem; 2017 Jun; 292(24):9988-10001. PubMed ID: 28446611 [TBL] [Abstract][Full Text] [Related]
15. The fifth subunit of the (α4β2) New K; Del Villar SG; Mazzaferro S; Alcaino C; Bermudez I Br J Pharmacol; 2018 Jun; 175(11):1822-1837. PubMed ID: 28600847 [TBL] [Abstract][Full Text] [Related]
17. Potentiation of a neuronal nicotinic receptor via pseudo-agonist site. Mazzaferro S; Bermudez I; Sine SM Cell Mol Life Sci; 2019 Mar; 76(6):1151-1167. PubMed ID: 30600358 [TBL] [Abstract][Full Text] [Related]